Wells Fargo raised the firm’s price target on Tenet Healthcare to $105 from $98 and keeps an Overweight rating on the shares. The firm cites improved underlying estimates and the recently announced CA divestiture. Valuation is above recent averages, but Wells thinks it is justified by improving business mix and leverage.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on THC:
- Tenet Healthcare price target raised to $109 from $97 at RBC Capital
- Tenet Healthcare price target raised to $100 from $75 at Deutsche Bank
- Tenet Healthcare price target raised to $105 from $92 at Truist
- Tenet Healthcare price target raised to $104 from $94 at Cantor Fitzgerald
- Tenet Healthcare price target raised to $100 from $90 at Mizuho
